Inhibitors of human immunodeficiency virus replication
AssigneeBristol-Myers Squibb Company
InventorsAnnapurna Pendri, Guo Li, John A. Bender, Zhong Yang, Alan Xiangdong Wang, Brett R. Beno, Robert A. Fridell, Makonen Belema, Nicholas A. Meanwell, Robert G. Gentles
Life of this patent
Estimating the term…
Abstract
Compounds of Formula I with activity against HIV, including pharmaceutical compositions and methods for using these compounds in treating human immunodeficiency virus (HIV) infection, are set forth: Formula: (I)
Claims20
A compound of Formula I, including pharmaceutically acceptable salts thereof:
- wherein:
- R1 is alkyl, aryl, arylalkyl, cycloalkyl or heteroaryl;
- wherein said aryl, arylalkyl or heteroaryl moieties are linked to the parent molecule through their respective carbon atoms, and further wherein said R1 groups are substituted with 0-4 groups independently selected from the group of alkenyl, alkoxy, alkoxycarbonyl, alkoxycarbonylamino, alkyl, alkylsulphonyl, alkylthioxy, aminocarbonyl, alkynyl, carboxylic acid, cyano, halo, haloalkyl, haloalkoxy, hydroxy, hydroxyalkyl, thioxy, —SO2alkyl, heteroaryl, and nitro;
- R2 is —H, C1-C4 alkyl or C3-C4 cycloalkyl;
- or R1 and R2 together with the atoms to which they are attached form a heterocyclic ring optionally substituted with 0-2 alkyl groups;
- R3 is —H, C1-C4 alkyl or C3-C4 cycloalkyl;
- R4 is —H, alkyl, aryl, C5-C10 bicycloalkyl, cycloalkyl or heteroaryl which is substituted with 0-3 groups independently selected from the group of alkenoxy, alkenyl, alkoxy, alkoxycarbonyl, alkyl, benzyloxy, carboamide, cyano, halo, haloalkyl, haloalkoxy, —NHCO(alkyl), —SO2N-heterocycle, —OH, nitro, and —CH2OH;
- R5 and R6 are independently selected from H or alkyl, or R5 and R4 together with the atom to which they are attached form an aryl group, or R5 and R6 together with the atoms to which they are attached form a C3-C4 cycloalkyl;
- R7 is —H, alkyl, aryl, heteroaryl, heteroarylalkyl, C3-C7 cycloalkyl or dialkylaminoalkyl, wherein said aryl or heteroaryl is substituted with 0-3 groups independently selected from the group of —OH, —NHCOalkyl, —NHCON(alkyl)2, —NHCO2-alkyl, —CONH2, —CN, —SO2N(alkyl)2, alkoxy, alkyl, halo, haloalkoxy, and haloalkyl;
- and
- R8 is —H, alkyl, arylalkyl, cycloalkyl, haloalkyl or heteroarylalkyl;
- or R7 and R8 together with the nitrogen atom to which they are attached form a heterocycle which is substituted with 0-3 groups independently selected from the group of alkyl, alkoxy, halo, —OH, —CN, and —SO2N(alkyl)2.
A compound, including pharmaceutically acceptable salts thereof, which is selected from the group of:
A compound, including pharmaceutically acceptable salts thereof, which is selected from the group of:
Dependencies are inferred from the claim text.